Correlation Between Dermata Therapeutics and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Monopar Therapeutics.
Diversification Opportunities for Dermata Therapeutics and Monopar Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dermata and Monopar is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Monopar Therapeutics
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 0.65 times more return on investment than Monopar Therapeutics. However, Dermata Therapeutics is 1.55 times less risky than Monopar Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 124.00 in Dermata Therapeutics on November 29, 2024 and sell it today you would lose (5.00) from holding Dermata Therapeutics or give up 4.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dermata Therapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Dermata Therapeutics |
| Monopar Therapeutics |
Dermata Therapeutics and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Monopar Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Dermata Therapeutics vs. Beam Therapeutics | Dermata Therapeutics vs. Editas Medicine | Dermata Therapeutics vs. Caribou Biosciences | Dermata Therapeutics vs. Verve Therapeutics |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |